Nehal Chopra’s Tiger Ratan Takes $300 Million Hit On Valeant Pharmaceuticals International Inc. – ValueWalk Premium
Nehal Chopra

Nehal Chopra’s Tiger Ratan Takes $300 Million Hit On Valeant Pharmaceuticals International Inc.

Bill Ackman's hedge fund, Pershing Square Capital Management may be the second biggest owner of Valeant Pharmaceuticals International Inc., but the fund's diversification has helped insulate it (somewhat) from the brunt of the stocks decline. Other hedge funds haven't been so lucky.

According to Reuters, Ackman's Pershing Square reported a decline of 6% to 7% for . . .

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk

0